Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 3-year Analysis of the KEEPsAKE 1 and 2 Trials. (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s249. https://doi.org/10.25251/skin.7.supp.249